Literature DB >> 19616747

Modeling plan-related clinical complications using machine learning tools in a multiplan IMRT framework.

Hao H Zhang1, Warren D D'Souza, Leyuan Shi, Robert R Meyer.   

Abstract

PURPOSE: To predict organ-at-risk (OAR) complications as a function of dose-volume (DV) constraint settings without explicit plan computation in a multiplan intensity-modulated radiotherapy (IMRT) framework. METHODS AND MATERIALS: Several plans were generated by varying the DV constraints (input features) on the OARs (multiplan framework), and the DV levels achieved by the OARs in the plans (plan properties) were modeled as a function of the imposed DV constraint settings. OAR complications were then predicted for each of the plans by using the imposed DV constraints alone (features) or in combination with modeled DV levels (plan properties) as input to machine learning (ML) algorithms. These ML approaches were used to model two OAR complications after head-and-neck and prostate IMRT: xerostomia, and Grade 2 rectal bleeding. Two-fold cross-validation was used for model verification and mean errors are reported.
RESULTS: Errors for modeling the achieved DV values as a function of constraint settings were 0-6%. In the head-and-neck case, the mean absolute prediction error of the saliva flow rate normalized to the pretreatment saliva flow rate was 0.42% with a 95% confidence interval of (0.41-0.43%). In the prostate case, an average prediction accuracy of 97.04% with a 95% confidence interval of (96.67-97.41%) was achieved for Grade 2 rectal bleeding complications.
CONCLUSIONS: ML can be used for predicting OAR complications during treatment planning allowing for alternative DV constraint settings to be assessed within the planning framework.

Entities:  

Mesh:

Year:  2009        PMID: 19616747      PMCID: PMC3346958          DOI: 10.1016/j.ijrobp.2009.02.065

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

1.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.

Authors:  A Eisbruch; R K Ten Haken; H M Kim; L H Marsh; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

Review 2.  Partial irradiation of the parotid gland.

Authors:  A Eisbruch; J A Ship; H M Kim; R K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2001-07       Impact factor: 5.934

Review 3.  Partial irradiation of the rectum.

Authors:  A Jackson
Journal:  Semin Radiat Oncol       Date:  2001-07       Impact factor: 5.934

4.  Exploration of tradeoffs in intensity-modulated radiotherapy.

Authors:  David Craft; Tarek Halabi; Thomas Bortfeld
Journal:  Phys Med Biol       Date:  2005-12-06       Impact factor: 3.609

5.  Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.

Authors:  L J Boersma; M van den Brink; A M Bruce; T Shouman; L Gras; A te Velde; J V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-04-01       Impact factor: 7.038

6.  How many plans are needed in an IMRT multi-objective plan database?

Authors:  David Craft; Thomas Bortfeld
Journal:  Phys Med Biol       Date:  2008-05-01       Impact factor: 3.609

7.  Multiobjective decision theory for computational optimization in radiation therapy.

Authors:  Y Yu
Journal:  Med Phys       Date:  1997-09       Impact factor: 4.071

8.  Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

Authors:  A Jackson; M W Skwarchuk; M J Zelefsky; D M Cowen; E S Venkatraman; S Levegrun; C M Burman; G J Kutcher; Z Fuks; S A Liebel; C C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-01       Impact factor: 7.038

9.  Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitis.

Authors:  Shifeng Chen; Sumin Zhou; Fang-Fang Yin; Lawrence B Marks; Shiva K Das
Journal:  Med Phys       Date:  2007-10       Impact factor: 4.071

10.  Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.

Authors:  Claudio Fiorino; Giuseppe Sanguineti; Cesare Cozzarini; Gianni Fellin; Franca Foppiano; Loris Menegotti; Anna Piazzolla; Vittorio Vavassori; Riccardo Valdagni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

View more
  6 in total

1.  The minimum knowledge base for predicting organ-at-risk dose-volume levels and plan-related complications in IMRT planning.

Authors:  Hao H Zhang; Robert R Meyer; Leyuan Shi; Warren D D'Souza
Journal:  Phys Med Biol       Date:  2010-03-12       Impact factor: 3.609

2.  Automatic assessment of average diaphragm motion trajectory from 4DCT images through machine learning.

Authors:  Guang Li; Jie Wei; Hailiang Huang; Carl Philipp Gaebler; Amy Yuan; Joseph O Deasy
Journal:  Biomed Phys Eng Express       Date:  2015-12-29

Review 3.  Big Data in Head and Neck Cancer.

Authors:  Carlo Resteghini; Annalisa Trama; Elio Borgonovi; Hykel Hosni; Giovanni Corrao; Ester Orlandi; Giuseppina Calareso; Loris De Cecco; Cesare Piazza; Luca Mainardi; Lisa Licitra
Journal:  Curr Treat Options Oncol       Date:  2018-10-25

4.  IMRT QA using machine learning: A multi-institutional validation.

Authors:  Gilmer Valdes; Maria F Chan; Seng Boh Lim; Ryan Scheuermann; Joseph O Deasy; Timothy D Solberg
Journal:  J Appl Clin Med Phys       Date:  2017-08-17       Impact factor: 2.102

5.  Confidence limits for patient-specific IMRT dose QA: a multi-institutional study in Korea.

Authors:  Jung-In Kim; Jin-Beom Chung; Ju-Young Song; Sung Kyu Kim; Yunseok Choi; Chang Heon Choi; Won Hoon Choi; Byungchul Cho; Jin Sung Kim; Sung Jin Kim; Sung-Joon Ye
Journal:  J Appl Clin Med Phys       Date:  2016-01-08       Impact factor: 2.102

Review 6.  Deep Learning: A Review for the Radiation Oncologist.

Authors:  Luca Boldrini; Jean-Emmanuel Bibault; Carlotta Masciocchi; Yanting Shen; Martin-Immanuel Bittner
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.